References
- O'Connor RC, Alsikafi NF, Steinberg GD. Therapeutic options and treatment of muscle invasive bladder cancer. Expert Rev Anticancer Ther 2001; 1: 511–22
- Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473–85
- Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol 1987; 138: 1402–6
- Tewari A, Peabody JO, Fischer M, Sarle R, Vallancien G, Delmas V. An operative and anatomic study to help in nerve sparing during laparoscopic and robotic radical prostatectomy. Eur Urol 2003; 43: 444–54
- Mostofi FK, Davies CJ, Sesterhenn IA. Histological typing of urinary bladder tumours. International classification of tumours, No. 102nd ed. World Health Organization, Geneva 1999
- Spitz A, Stein JP, Lieskovsky G, Skinner DG. Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J Urol 1999; 161: 1761–4
- Studer UE, Turner WH. The ileal orthotopic bladder. Urology 1995; 45: 185–9
- Wallace DM. Uretero-ileostomy. Br J Urol 1970; 42: 529–34
- Henningsohn L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G. Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a Swedish population-based study. Eur Urol 2001; 40: 151–62
- Botto H, Sebe P, Molinie V, Herve JM, Yonneau L, Lebret T. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients. BJU Int 2004; 94: 1021–5
- Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006; 176: 486–92
- Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466–5
- Montie JE, Wood DP, Jr, Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 1989; 63: 381–5
- Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA, Jr, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004; 171: 646–51
- Kouriefs C, Fazili T, Masood S, Naseem MS, Mufti GR. Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int 2005; 75: 213–6
- Vallancien G, Abou El Fettouh H, Cathelineau X, Baumert H, Fromont G, Guillonneau B. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 2002; 168: 2413–7
- Horenblas S, Meinhardt W, Ijzerman W, Moonen LF. Sexuality preserving cystectomy and neobladder: initial results. J Urol 2001; 166: 837–40
- Muto G, Bardari F, D'Urso L, Giona C. Seminal sparing cystectomy and ileocapsuloplasty: longterm followup results. J Urol 2004; 172: 76–80
- Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004; 172: 1323–7
- Månsson Å, Henningsohn L, Steineck G, Månsson W. Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. Eur Urol 2004; 46: 195–9